Effect of imidocarb and levamisole on the experimental infection of BALB/c mice by Leishmania (Leishmania) amazonensis

Veterinary Parasitology
Flavio H RodriguesMaria A de Souza

Abstract

The adverse effects from using currently available drugs for the treatment of leishmaniasis have motivated the search for new therapeutical agents. The aim of this work was to evaluate the effect of imidocarb and levamisole on the treatment of BALB/c mice experimentally infected by Leishmania (Leishmania) amazonensis. BALB/c mice were infected with 10(6) promastigotes of L. (L.) amazonensis (IFLA/BR/67/PH8) and, starting on day 51, mice were treated subcutaneously with imidocarb (IMD, 34 mg/kg), imidocarb plus levamisole (IMD+LVS, 34 and 12 mg/kg, respectively), only levamisole (LVS, 12 mg/kg) or without treatment (control). Lesion size and swelling were weekly monitored for 10 weeks after the beginning of the treatment. On day 121 post-infection, serum levels of specific IgG from infected mice were evaluated, as well as histopathological and morphometric alterations in the footpad, lymph nodes and spleen of these animals. The data obtained in this study demonstrated that, when compared to controls, mice treated with IMD had lower levels of IgG anti-L. (L.) amazonensis (34.45%), smaller vacuolar area in macrophages (3.75%), lower number of megakaryocytes in spleen (63.19%) and lower parasite burden in the footpad (30.2%). Thus,...Continue Reading

References

Mar 1, 1992·The American Journal of Tropical Medicine and Hygiene·B L Herwaldt, J D Berman
Mar 1, 1995·Memórias do Instituto Oswaldo Cruz·H L LenziD N Oliveira
Oct 1, 1996·Toxicology Letters·A S MooreM J Sauer
Jan 1, 1997·International Journal of Dermatology·K A BahamdanM M Nauri
May 18, 2000·Biochemical and Biophysical Research Communications·K Igarashi, K Kashiwagi
Aug 30, 2001·European Journal of Medicinal Chemistry·I O DonkorC Bacchi
Nov 13, 2001·Tropical Medicine & International Health : TM & IH·S Sundar
Mar 22, 2002·The New England Journal of Medicine·Abdulrahman A AlrajhiJames H Maguire
Nov 27, 2002·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Diana TetiHarold McNair
May 21, 2003·Journal of Veterinary Pharmacology and Therapeutics·F BozićI Valpotić
Jul 16, 2003·International Immunopharmacology·Paul H Naylor, John W Hadden
Sep 3, 2003·Biochemical and Biophysical Research Communications·Toyoko KatayamaShinzo Oikawa
Sep 19, 2003·International Journal of Antimicrobial Agents·Clara Leandro, Lenea Campino
Oct 29, 2003·Trends in Parasitology·Simon L Croft, Graham H Coombs
May 12, 2004·Veterinary Parasitology·A L Abreu-SilvaS C Gonçalves da Costa
Jul 13, 2004·Vaccine·Huali JinBin Wang
Dec 23, 2004·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Sarman Singh, Ramu Sivakumar
Mar 9, 2005·The Journal of Experimental Medicine·Suzanne A MilesDavid M Mosser

❮ Previous
Next ❯

Citations

Nov 21, 2007·The Veterinary Journal·P Gómez-OchoaC G Couto
Aug 15, 2017·Parasitology·Rebecca L CharltonPatrick G Steel
Feb 27, 2009·Journal of Agricultural and Food Chemistry·Zhongjie WangWenxue Wu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.